Movano Inc. Reports Q3 2025 Financial Results
Movano Inc. reported a Q3 2025 net loss of $4.03 million, down from $7.20 million last year. Revenue rose to $80,000, but high expenses led to continued losses. Cash reserves fell from $7.9 million to $2 million. Movano entered a merger with Corvex, Inc., raised $1.5 million via a bridge loan, and seeks further financing to sustain operations beyond Q1 2026. Management focuses on completing the merger and securing additional capital.
Movano, Inc. ( (MOVE) ) has released its Q3 earnings. Here is a breakdown of the information Movano, Inc. presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Movano Inc., a technology company in the healthcare sector, is developing a platform to deliver medical-grade data through consumer health devices. In its latest earnings report for the quarter ending September 30, 2025, Movano Inc. reported a net loss of $4.03 million, a decrease from the $7.20 million loss in the same quarter last year. The company’s revenue increased to $80,000 from $50,000 in the previous year, but costs and expenses were significantly higher, leading to continued losses. The company also reported a substantial decrease in cash and cash equivalents, from $7.9 million at the end of 2024 to $2 million at the end of September 2025. Movano Inc. has entered into a merger agreement with Corvex, Inc., and raised additional capital through various financing activities, including a $1.5 million bridge loan. The company anticipates the need for further financing to support its operations beyond the first quarter of 2026. Movano’s management remains focused on completing the merger and securing additional capital to sustain its operations and continue its development efforts.
